circ axl (Proteostasis Therapeutics)
Structured Review

Circ Axl, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/circ+axl/axl+circ/pmc13018962-7-7-0
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Non-coding RNAs in neurodegeneration: an axis-based, evidence-tiered mechanistic synthesis"
Article Title: Non-coding RNAs in neurodegeneration: an axis-based, evidence-tiered mechanistic synthesis
Journal: Metabolism Open
doi: 10.1016/j.metop.2026.100458
Figure Legend Snippet: The primary roles of circRNAs. ( A ) circRNAs may function as sponges for miRNAs, as shown by circ-AXL, which has target sites for miR-328. ( B ) circRNAs may engage with certain mRNAs and modulate their stability and/or translation. An instance is the circ-Bptf interaction with p62 mRNA. ( C ) CircRNAs may be translated to yield tiny peptides, as shown by the translation of circCDYL2 into the Cdyl2-60aa peptide, which is around 7 kDa. ( D ) CircRNAs with motifs that can bind to RNA-binding proteins have the ability to function as decoys or sponges for these proteins, therefore regulating their activity. CircRNAs with patterns that promote the interaction between an enzyme and its substrate may function as scaffolds, facilitating the co-localization of the two entities and enhancing reaction kinetics. CircRNAs may engage with gene promoters, recruit TET1 demethylase, and induce substantial demethylation of CpG islands in the DNA. CircRNAs may bind to U1 snRNP and then interact with the RNA polymerase II transcription complex, hence increasing protein expression. snRNA refers to small nuclear RNA, whereas snRNP denotes small nuclear ribonucleoprotein.
Techniques Used: RNA Binding Assay, Activity Assay, Expressing
Related Articles
Expressing:Article Title: Non-coding RNAs in neurodegeneration: an axis-based, evidence-tiered mechanistic synthesis Article Snippet: Proteostasis/Protein aggregation , ALS , lncRNA , Multiple , Ubiquitination, autophagy-lysosome flux, proteasome stress , Human/Cell line , Expression + perturbation , Tier 2 , Therapeutic target preclinical , [ , ] . .. Proteostasis/Protein aggregation , AD , circRNA , |